» Articles » PMID: 38809483

In Vitro Antibacterial Activity and Secondary Metabolite Profiling of Endolichenic Fungi Isolated from Genus Parmotrema

Overview
Journal Curr Microbiol
Specialty Microbiology
Date 2024 May 29
PMID 38809483
Authors
Affiliations
Soon will be listed here.
Abstract

The endolichenic fungi are an unexplored group of organisms for the production of bioactive secondary metabolites. The aim of the present study is to determine the antibacterial potential of endolichenic fungi isolated from genus Parmotrema. The study is continuation of our previous work, wherein a total of 73 endolichenic fungi were isolated from the lichenized fungi, which resulted in 47 species under 23 genera. All the isolated endolichenic fungi were screened for preliminary antibacterial activity. Five endolichenic fungi-Daldinia eschscholtzii, Nemania diffusa, Preussia sp., Trichoderma sp. and Xylaria feejeensis, were selected for further antibacterial activity by disc diffusion method. The zone of inhibition ranged from 14.3 ± 0.1 to 23.2 ± 0.1. The chemical composition of the selected endolichenic fungi was analysed through GC-MS, which yielded a total of 108 compounds from all the selected five endolichenic fungi. Diethyl phthalate, 1-hexadecanol, dibutyl phthalate, n-tetracosanol-1, 1-nonadecene, pyrrol[1,2-a] pyrazine-1,4-dione, hexahydro-3-(2-methyl) and tetratetracontane were found to be common compounds among one or the other endolichenic fungi, which possibly were responsible for antibacterial activity. GC-MS data were further analysed through Principal Component Analysis which showed D. eschscholtzii to be with unique pattern of expression of metabolites. Compound confirmation test revealed coumaric acid to be responsible for antibacterial activity in D. eschscholtzii. So, the study proves that endolichenic fungi that inhabit lichenized fungal thalli could be a source of potential antibacterial compounds.

References
1.
Baker R, Mahmud A, Miller I, Rajeev M, Rasambainarivo F, Rice B . Infectious disease in an era of global change. Nat Rev Microbiol. 2021; 20(4):193-205. PMC: 8513385. DOI: 10.1038/s41579-021-00639-z. View

2.
Atanasov A, Zotchev S, Dirsch V, Supuran C . Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021; 20(3):200-216. PMC: 7841765. DOI: 10.1038/s41573-020-00114-z. View

3.
Pham J, Yilma M, Feliz A, Majid M, Maffetone N, Walker J . A Review of the Microbial Production of Bioactive Natural Products and Biologics. Front Microbiol. 2019; 10:1404. PMC: 6596283. DOI: 10.3389/fmicb.2019.01404. View

4.
Biosca E, Flores R, Santander R, Diez-Gil J, Barreno E . Innovative Approaches Using Lichen Enriched Media to Improve Isolation and Culturability of Lichen Associated Bacteria. PLoS One. 2016; 11(8):e0160328. PMC: 4975499. DOI: 10.1371/journal.pone.0160328. View

5.
Muggia L, Fleischhacker A, Kopun T, Grube M . Extremotolerant fungi from alpine rock lichens and their phylogenetic relationships. Fungal Divers. 2016; 76:119-142. PMC: 4739527. DOI: 10.1007/s13225-015-0343-8. View